Zolmitriptan Impurity 13

A validated chiral LC method for the determination of Zolmitriptan and its potential impurities
M.K.Srinivasu, B. Malli karjunRao,G.Sridhar, P. Rajender Kumar, K.B.Chandrasekhar, Aminul Islamd
Journal of Pharmaceutical and Biomedical Analysis Volume 37, Issue 3, 9 March 2005, Pages 453-460
 
Analytical Quality by Design in pharmaceutical quality assurance: Development of a capillary electrophoresis method for the analysis of zolmitriptan and its impurities
Serena Orlandini  Benedetta Pasquini  Claudia Caprini  Massimo Del Bubba  Sergio Pinzauti  Sandra Furlanetto
Electrophoresis Volume36, Issue21-22 Special Issue: Electromigration Techniques in Pharmaceutical Analysis November 2015 Pages 2642-2649
 
A New Stability Indicating HPLC Method for Related Substances in Zolmitriptan
E. K. S. Vijayakumar, M. A. Samel, S. B. Bhalekar, and S. M. Pakhale
Indian J Pharm Sci. 2010 Jan-Feb; 72(1): 119–122.

Zolmitriptan Impurity 13 is chemically 3,3-Diethoxy-N,N-dimethylpropan-1-amine. Zolmitriptan Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Zolmitriptan Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zolmitriptan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.